Latest immunotherapy news
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
posted August 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma
posted August 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
posted August 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Related Articles
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
